STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention

NACompletedINTERVENTIONAL
Enrollment

12,386

Participants

Timeline

Start Date

September 10, 2018

Primary Completion Date

August 18, 2019

Study Completion Date

March 31, 2021

Conditions
Hepatitis CHepatoCellular Carcinoma
Interventions
BEHAVIORAL

Mailed outreach

The investigators will randomize all baby boomer patients (\~12,000 patients) using a centrally maintained computer-generated list. Patients will be randomly assigned to one of two HCV screening strategies including: visit-based screening as part of usual care (Group 1) or mailed screening invitation outreach and centralized patient navigation (Group 2).

Trial Locations (1)

75235

Parkland Hospital, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER

NCT03706742 - STOP HCC: Mailed HCV Treatment Outreach Program for HCC Prevention | Biotech Hunter | Biotech Hunter